Vital Innovations Narrows Annual Loss as Revenue Slumps and Margins Stay Thin

An announcement from Vital Innovations Holdings Ltd. ( (HK:6133) ) is now available.

Vital Innovations Holdings Ltd. reported a sharp decline in revenue to RMB 668.9 million for the year ended 31 December 2025, down from RMB 1.06 billion a year earlier, reflecting weaker sales despite a modest gross profit. The group remained loss-making, posting a net loss of RMB 17.7 million, though this narrowed from RMB 21.0 million in 2024 as administrative and finance costs declined and other gains turned positive, signaling some improvement in cost control but continued pressure on profitability and shareholder returns.

Gross profit fell to RMB 3.5 million from RMB 6.0 million, underscoring the strain on margins as cost of sales nearly matched revenue during the year. With no income tax charge recorded and losses attributable entirely to the company’s owners, the results highlight ongoing challenges in scaling sustainable earnings, keeping the business in a fragile financial position and raising questions about its ability to strengthen its balance sheet without further strategic changes.

The most recent analyst rating on (HK:6133) stock is a Hold with a HK$0.19 price target. To see the full list of analyst forecasts on Vital Innovations Holdings Ltd. stock, see the HK:6133 Stock Forecast page.

More about Vital Innovations Holdings Ltd.

Vital Innovations Holdings Ltd., incorporated in the Cayman Islands and listed in Hong Kong, operates through a group structure focused on trading and related commercial activities in mainland China and surrounding markets. The company generates revenue primarily in renminbi and is exposed to competitive pressures that keep margins thin and operating costs relatively high.

Average Trading Volume: 54,392

Technical Sentiment Signal: Buy

Current Market Cap: HK$225.2M

Find detailed analytics on 6133 stock on TipRanks’ Stock Analysis page.